Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.
about
Hypoxia: The Force that Drives Chronic Kidney DiseaseErythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular eventsMitochondria-targeted antioxidant MitoQ reduced renal damage caused by ischemia-reperfusion injury in rodent kidneys: Longitudinal observations of T2 -weighted imaging and dynamic contrast-enhanced MRI.Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injuryA nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusionInhibition of IκB Kinase Attenuates the Organ Injury and Dysfunction Associated with Hemorrhagic ShockProteome Analysis of Renoprotection Mediated by a Novel Cyclic Helix B Peptide in Acute Kidney Injury.ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury.Cyclic Helix B Peptide in Preservation Solution and Autologous Blood Perfusate Ameliorates Ischemia-Reperfusion Injury in Isolated Porcine Kidneys.Protective effects of HBSP on ischemia reperfusion and cyclosporine a induced renal injury.Designing drugs that combat kidney damage.Inhibition of IκB Kinase at 24 Hours After Acute Kidney Injury Improves Recovery of Renal Function and Attenuates FibrosisRenoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injury.Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.Non-erythropoietic erythropoietin-derived peptide protects mice from systemic lupus erythematosus.
P2860
Q26768865-ED9EB75E-7EAA-4D3D-8D8E-53C6B2C662CAQ26866295-6518DE36-A213-43B1-9691-FB92E16FF830Q30491988-B317F208-55CF-44E3-8F6A-25D0FD2C99E8Q33982388-CA55B9F2-447F-4BFD-A8DF-2F5759A86D9CQ35193649-C9E64D31-E08E-4A0E-AC12-B2FB0721A3FDQ36167076-D4C8728D-9498-4C1A-BBFC-5CFD512D5BDCQ36361390-B41A60E8-D34A-4E16-A642-1C3B1BFD605FQ36597266-2FED4660-179F-4E3A-AA4F-9966D73CE832Q37097716-E6D23C02-B155-40F4-A58D-B646A7AB417DQ37299978-2AA8817F-197B-4240-9E01-C9E50B3D90B3Q38404587-170BBEFE-C159-48ED-9CCD-26B6D598AFC7Q41627131-FA91B2BD-68EB-4F60-8D64-1524A4F1C7E5Q41833621-7646E8C5-B263-470F-BE0C-7C679C41B450Q48124687-940E99AB-9A05-45F9-8591-5A9A24E94DD3Q55400853-DDD31B8E-0F83-44B6-9BAF-F1BD672E7EB4
P2860
Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Delayed administration of pyro ...... ttenuates acute kidney injury.
@ast
Delayed administration of pyro ...... ttenuates acute kidney injury.
@en
type
label
Delayed administration of pyro ...... ttenuates acute kidney injury.
@ast
Delayed administration of pyro ...... ttenuates acute kidney injury.
@en
prefLabel
Delayed administration of pyro ...... ttenuates acute kidney injury.
@ast
Delayed administration of pyro ...... ttenuates acute kidney injury.
@en
P2093
P2860
P1433
P1476
Delayed administration of pyro ...... ttenuates acute kidney injury.
@en
P2093
Anthony Cerami
Elizabeth G Wood
Florence L Johnson
Hannah L Kerr-Peterson
Mara Rogazzo
Massimo Collino
Michael Brines
Muhammad M Yaqoob
Nimesh S A Patel
Roberto Fantozzi
P2860
P2888
P304
P356
10.2119/MOLMED.2012.00093
P407
P577
2012-05-09T00:00:00Z
P5875
P6179
1068965529